Mechanisms of drug-eluting stent restenosis.

Cardiovascular Intervention and Therapeutics
Jiro Aoki, Kengo Tanabe

Abstract

Drug-eluting stents (DES) were developed to overcome in-stent restenosis (ISR), which has long been considered the main complication limiting the long-term efficacy of coronary stenting. New-generation DES which composed of advanced stent design with and without specific biocompatible polymer contributes a reduction of the incidence of ISR to rate ranging from 5 to 10%. The precise reasons of DES restenosis are still controversial and not fully understood. Angiographic and coronary images at the index procedure, systemic status of patients, medications, and intracoronary imaging at ISR site are all considered to find the possible mechanisms of DES restenosis. Multiple biological, genetic, mechanical, and technical factors might intricately contribute to DES restenosis. Biological and genetic factors of ISR are not able to be sufficiently modified by the current medical approaches. Tailored treatments avoiding mechanical and technical factors of ISR are required to reduce DES restenosis. Elucidation of DES restenosis leads to further improvement in the current DES system and finds the optimal approach to treat DES restenosis. The possible mechanisms of DES restenosis are discussed in this review.

References

Aug 1, 1995·European Heart Journal·M HamonM E Bertrand
Nov 6, 2001·Journal of the American College of Cardiology·D H WalterA M Zeiher
May 29, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·S Huang, P J Houghton
Jun 7, 2002·The New England Journal of Medicine·Marie-Claude MoriceUNKNOWN RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patie
Feb 7, 2003·Current Cancer Drug Targets·R Z YusufM V Seiden
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators
Oct 25, 2003·Oncogene·George A OrrSusan Band Horwitz
Apr 6, 2004·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Francesco SaiaPatrick W Serruys
Jan 29, 2005·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ioannis IakovouAntonio Colombo
Mar 30, 2005·Circulation·Chao-Wei HwangElazer R Edelman
May 4, 2005·Circulation·Marco A Costa, Daniel I Simon
Oct 19, 2005·Circulation·Pascalle S MonraatsJ Wouter Jukema
Dec 2, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Pascalle S MonraatsJ Wouter Jukema
Feb 3, 2006·The New England Journal of Medicine·Patrick W SerruysAndrew T L Ong
Jul 4, 2006·Journal of the American College of Cardiology·Dean J KereiakesJeffrey W Moses
Dec 30, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Jiro AokiKazuhiro Hara
Jan 10, 2008·Journal of Thrombosis and Haemostasis : JTH·K M KatsarosG Christ
Jul 9, 2008·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Giuseppe FerranteFilippo Crea
Nov 17, 2009·Journal of the American College of Cardiology·Gaku NakazawaRenu Virmani
Mar 20, 2010·Journal of the American College of Cardiology·Lorenz RäberStephan Windecker
Jun 11, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Yoshihiro MorinoYuji Ikari
Jun 18, 2010·The New England Journal of Medicine·Patrick W SerruysStephan Windecker
Nov 20, 2010·Journal of the American College of Cardiology·Giampaolo NiccoliFilippo Crea
Nov 27, 2010·Journal of the American College of Cardiology·George D DangasRoxana Mehran
Apr 21, 2011·Circulation. Cardiovascular Interventions·Vasim FarooqPatrick W Serruys
Sep 14, 2011·Nature Reviews. Cardiology·J Wouter JukemaPaul H A Quax
Jan 14, 2012·JACC. Cardiovascular Imaging·Masataka NakanoRenu Virmani
Apr 7, 2012·Journal of the American College of Cardiology·Konstantinos C KoskinasGeorge D Giannoglou
Jun 2, 2012·Journal of the American College of Cardiology·Seung-Jung ParkYasunori Ueda
Sep 27, 2012·Circulation. Cardiovascular Interventions·Shoichi KuramitsuMasakiyo Nobuyoshi
Feb 26, 2013·The American Journal of Cardiology·Soo-Jin KangSeung-Jung Park
Sep 26, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Crochan J O'SullivanStephan Windecker
Apr 17, 2014·Circulation. Cardiovascular Interventions·Mitul B KadakiaRobert L Wilensky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American College of Cardiology
George D DangasRoxana Mehran
EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Jose Ribamar CostaJose Eduardo Sousa
Cardiovascular Revascularization Medicine : Including Molecular Interventions
Bryan P YanRon Waksman
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology
Patrizia Presbitero, Giacomo Boccuzzi
© 2021 Meta ULC. All rights reserved